Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Myriad Genetics, Inc. Income Statement Banner

Myriad Genetics, Inc. Income Statement

MYGN Stock Analysis

Page title

Section title

Breakdown
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Total Revenue
778.216M723.100M753.800M771.400M772.600M851.100M851.100M557.000M690.600M678.400M
Cost of Revenue
109.201M147.400M157.300M171.200M177.200M201.000M201.000M178.200M197.600M202.000M
Gross Profit
669.015M575.700M596.500M600.200M595.400M650.100M650.100M378.800M493.000M476.400M
Operating Expense
394.573M441.500M429.700M550.800M537.900M641.400M641.400M653.300M681.700M600.100M
Operating Income
274.442M134.200M166.800M49.400M118.700M7.600M7.600M-194.800m-48.700m-123.700m
Other Income Expense
-1.974m300.000K1.200M-2.500m-400.000k1.200M1.200M0.000139.300M600.000K
Total Other Income Expense
-1.974m300.000K1.200M-1.700m60.800M100.000K100.000K-88.900m-8.400m-16.900m
Pretax Income
277.865M134.900M168.900M42.900M116.900M7.700M200.000K-283.700m-57.100m-140.600m
Tax Provision
101.640M54.700M43.600M21.300M-13.900m-4.400m-4.400m59.900M-29.900m-28.600m
Net Income
176.225M80.200M125.300M21.800M131.000M4.600M4.600M-223.700m-27.200m-112.000m
Basic EPS
2.3301.1201.7900.3201.8900.0600.063-2.990-0.350-1.390
Diluted EPS
2.2501.0801.7100.3201.8200.0600.061-2.990-0.350-1.390
Basic Average Shares
75.728M71.300M70.000M68.300M69.400M73.500M73.500M74.699M77.714M80.576M
Diluted Average Shares
78.182M74.500M73.400M68.800M72.000M76.000M76.000M74.775M78.000M80.600M
Total Expenses
503.774M588.900M587.000M722.000M715.100M842.400M842.400M831.500M879.300M802.100M
Interest Income
5.397M400.000K900.000K1.200M1.800M3.200M3.200M9.200M700.000K2.600M
Interest Expense
0.0000.0000.0006.000M3.200M12.000M12.000M0.0006.600M3.200M
EBITDA
274.442M159.200M193.500M96.400M113.300M86.100M86.100M-123.400m14.100M-67.800m
Depreciation & Amortization
13.819M25.000M26.700M48.300M54.400M73.000M73.000M71.400M62.800M55.900M